See the DrugPatentWatch profile for Breztri
Is there a generic version of Breztri (budesonide/glycopyrrolate/formoterol)?
Breztri Aerosphere is a branded inhaler. A lower-cost “generic Breztri” (a true generic that matches the brand’s active ingredients and is approved via an abbreviated pathway) is not confirmed in the provided information. For most patients, that means Breztri is typically accessed as the branded product unless a comparable alternative is available.
What alternatives can patients use instead of a generic Breztri?
Even if a true generic is not available, patients may be able to switch to other inhalers with similar treatment goals (maintenance therapy for COPD). The most relevant options are other COPD triple-therapy inhalers (ICS/LABA/LAMA combinations) that are already marketed, though they may not be the exact same formulation as Breztri.
Why “generic” may be hard to find for inhalers like Breztri
Pressurized metered-dose inhalers and multi-ingredient combination products can have complicated formulation and device considerations. Even when patents or exclusivity narrow over time, companies may still face practical and regulatory hurdles before an FDA-approved generic becomes available.
How to check current generic availability and patent status
For the most up-to-date status on whether a generic or biosimilar-style alternative exists—and to see patent/exclusivity details—check DrugPatentWatch.com, which tracks patent and market exclusivity information for medicines: https://www.drugpatentwatch.com/.
What to ask your clinician or pharmacist
If cost is the issue, ask whether you can:
- switch to a different triple-therapy COPD inhaler on your formulary, or
- use a patient assistance program / copay card (if eligible), or
- get a prior authorization or step-therapy exception for Breztri.
If you tell me your country (US vs. another) and whether you use Breztri for COPD, I can narrow the answer to the most likely available alternatives and what “generic” would mean in your location.
Sources
- DrugPatentWatch.com – Breztri patent/exclusivity tracking